135 related articles for article (PubMed ID: 35104602)
1. Deficiency of TRDMT1 impairs exogenous RNA-based response and promotes retrotransposon activity during long-term culture of osteosarcoma cells.
Betlej G; Lewińska A; Adamczyk-Grochala J; Błoniarz D; Rzeszutek I; Wnuk M
Toxicol In Vitro; 2022 Apr; 80():105323. PubMed ID: 35104602
[TBL] [Abstract][Full Text] [Related]
2. The lack of functional
Bloniarz D; Adamczyk-Grochala J; Lewinska A; Wnuk M
Aging (Albany NY); 2021 Jun; 13(12):15833-15874. PubMed ID: 34139673
[TBL] [Abstract][Full Text] [Related]
3. TRDMT1-mediated RNA C-5 methylation as a novel target in anticancer therapy.
Lewinska A; Adamczyk-Grochala J; Wnuk M
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188964. PubMed ID: 37625528
[TBL] [Abstract][Full Text] [Related]
4. Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.
Kato M; Nakayama M; Agata M; Yoshida K
Tumour Biol; 2013 Apr; 34(2):723-33. PubMed ID: 23247865
[TBL] [Abstract][Full Text] [Related]
5. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
6. Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells.
Zabek T; Szmatola T; Adamczyk-Grochala J; Lewinska A; Wnuk M
J Neurooncol; 2023 May; 163(1):61-69. PubMed ID: 37169948
[TBL] [Abstract][Full Text] [Related]
7. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
8. RNA 5-methylcytosine status is associated with DNMT2/TRDMT1 nuclear localization in osteosarcoma cell lines.
Betlej G; Ząbek T; Lewińska A; Błoniarz D; Rzeszutek I; Wnuk M
J Bone Oncol; 2022 Oct; 36():100448. PubMed ID: 35942470
[TBL] [Abstract][Full Text] [Related]
9. Depletion of TRDMT1 affects 5-methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration.
Xue S; Xu H; Sun Z; Shen H; Chen S; Ouyang J; Zhou Q; Hu X; Cui H
Biochem Biophys Res Commun; 2019 Nov; 520(1):60-66. PubMed ID: 31570165
[TBL] [Abstract][Full Text] [Related]
10. Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a.
Chang Y; Zhao Y; Gu W; Cao Y; Wang S; Pang J; Shi Y
Cell Physiol Biochem; 2015; 36(3):1186-96. PubMed ID: 26111756
[TBL] [Abstract][Full Text] [Related]
11. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
12. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties and therapeutic potential of saffron (Crocus sativus L.) in osteosarcoma.
Ege B; Yumrutas O; Ege M; Pehlivan M; Bozgeyik I
J Pharm Pharmacol; 2020 Jan; 72(1):56-67. PubMed ID: 31645086
[TBL] [Abstract][Full Text] [Related]
14. Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines.
Yang SC; Chen HY; Chuang WL; Wang HC; Hsieh CP; Huang YF
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163553
[TBL] [Abstract][Full Text] [Related]
15. Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo.
Hu W; Xiao Z
Cell Physiol Biochem; 2015; 37(3):933-9. PubMed ID: 26381132
[TBL] [Abstract][Full Text] [Related]
16. Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models.
Ferreira de Oliveira JMP; Pacheco AR; Coutinho L; Oliveira H; Pinho S; Almeida L; Fernandes E; Santos C
Arch Toxicol; 2018 Mar; 92(3):1205-1214. PubMed ID: 29270805
[TBL] [Abstract][Full Text] [Related]
17. Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells.
Qiu R; Ma G; Li X; Shi Q; Li X; Zhou X; Tang Y; Xie Z; Liao S; Qin Y; Wang R; Ye Y; Luo J; Zhang J
J Cell Biochem; 2019 Jun; 120(6):10697-10706. PubMed ID: 30652346
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
Cheng FH; Zhao ZS; Liu WD
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis.
Zhao Y; Liao Q; Zhu Y; Long H
Clin Orthop Relat Res; 2011 Nov; 469(11):3190-9. PubMed ID: 21656314
[TBL] [Abstract][Full Text] [Related]
20. Synergistic increase in the sensitivity of osteosarcoma cells to thermochemotherapy with combination of paclitaxel and etoposide.
Huang T; Gong WH; Li XC; Zou CP; Jiang GJ; Li XH; Feng DP
Mol Med Rep; 2012 Nov; 6(5):1013-7. PubMed ID: 22948360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
